The clinical utility of epoetin in cancer patients: a matter of perspective

Haematologica. 2000 May;85(5):449-50.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anemia / drug therapy
  • Anemia / etiology
  • Anemia / prevention & control
  • Antineoplastic Agents / adverse effects
  • Cost-Benefit Analysis
  • Erythrocyte Transfusion / economics
  • Erythrocyte Transfusion / standards
  • Erythropoietin / economics
  • Erythropoietin / therapeutic use*
  • Humans
  • Neoplasms / complications*
  • Neoplasms / economics
  • Neoplasms / therapy
  • Recombinant Proteins / economics
  • Recombinant Proteins / therapeutic use

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Erythropoietin